Concepts (244)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Saccharomyces cerevisiae | 12 | 2022 | 463 | 3.010 |
Why?
|
| Heat-Shock Response | 5 | 2024 | 54 | 2.700 |
Why?
|
| Saccharomyces cerevisiae Proteins | 10 | 2022 | 301 | 2.200 |
Why?
|
| Protein Biosynthesis | 10 | 2015 | 399 | 1.940 |
Why?
|
| Evolution, Molecular | 12 | 2013 | 891 | 1.470 |
Why?
|
| Poly(A)-Binding Proteins | 3 | 2024 | 10 | 1.470 |
Why?
|
| Heat-Shock Proteins | 4 | 2022 | 184 | 1.440 |
Why?
|
| Kidney Calculi | 7 | 2015 | 345 | 1.220 |
Why?
|
| Stress, Physiological | 3 | 2024 | 252 | 0.990 |
Why?
|
| Protein Folding | 8 | 2022 | 295 | 0.920 |
Why?
|
| Proteins | 8 | 2010 | 816 | 0.910 |
Why?
|
| Cytoplasmic Granules | 3 | 2021 | 99 | 0.800 |
Why?
|
| Gene Expression | 4 | 2015 | 1320 | 0.760 |
Why?
|
| DNA-Binding Proteins | 2 | 2020 | 1267 | 0.760 |
Why?
|
| Selection, Genetic | 7 | 2014 | 537 | 0.740 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 2022 | 18 | 0.730 |
Why?
|
| HSP70 Heat-Shock Proteins | 2 | 2022 | 118 | 0.730 |
Why?
|
| Fungal Proteins | 2 | 2013 | 147 | 0.700 |
Why?
|
| Models, Genetic | 6 | 2015 | 983 | 0.690 |
Why?
|
| Transcription Factors | 3 | 2020 | 1730 | 0.670 |
Why?
|
| Calcium Oxalate | 4 | 2015 | 188 | 0.640 |
Why?
|
| Calcium Phosphates | 3 | 2015 | 84 | 0.630 |
Why?
|
| Hypercalciuria | 3 | 2015 | 47 | 0.610 |
Why?
|
| Phase Transition | 1 | 2019 | 18 | 0.600 |
Why?
|
| Ribosomes | 3 | 2015 | 122 | 0.600 |
Why?
|
| Codon | 3 | 2014 | 120 | 0.590 |
Why?
|
| Organelles | 1 | 2019 | 58 | 0.580 |
Why?
|
| Saccharomycetales | 2 | 2013 | 15 | 0.510 |
Why?
|
| Cytosol | 2 | 2020 | 198 | 0.490 |
Why?
|
| Open Reading Frames | 2 | 2014 | 124 | 0.450 |
Why?
|
| Nucleoside Q | 1 | 2014 | 10 | 0.440 |
Why?
|
| RNA Stability | 1 | 2015 | 97 | 0.440 |
Why?
|
| Genome, Insect | 1 | 2014 | 78 | 0.430 |
Why?
|
| Genetic Fitness | 2 | 2013 | 45 | 0.420 |
Why?
|
| Kidney Tubules, Proximal | 2 | 2015 | 61 | 0.420 |
Why?
|
| Kidney Tubules | 2 | 2015 | 93 | 0.410 |
Why?
|
| RNA, Transfer | 1 | 2014 | 173 | 0.380 |
Why?
|
| Calcium | 4 | 2015 | 1205 | 0.380 |
Why?
|
| Amino Acid Substitution | 4 | 2009 | 336 | 0.360 |
Why?
|
| Drosophila | 1 | 2014 | 539 | 0.320 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2020 | 509 | 0.320 |
Why?
|
| Biophysical Phenomena | 1 | 2010 | 125 | 0.320 |
Why?
|
| Genome | 2 | 2010 | 407 | 0.320 |
Why?
|
| Protein Aggregates | 2 | 2022 | 28 | 0.300 |
Why?
|
| Transcriptome | 2 | 2018 | 769 | 0.290 |
Why?
|
| Mutation | 5 | 2013 | 4374 | 0.290 |
Why?
|
| X-Ray Microtomography | 2 | 2014 | 102 | 0.260 |
Why?
|
| Recombination, Genetic | 2 | 2007 | 444 | 0.250 |
Why?
|
| Mutagenesis | 3 | 2017 | 202 | 0.240 |
Why?
|
| Parathyroid Hormone | 2 | 2015 | 228 | 0.240 |
Why?
|
| Nephrocalcinosis | 1 | 2015 | 9 | 0.230 |
Why?
|
| beta-Lactamases | 2 | 2005 | 57 | 0.230 |
Why?
|
| Renal Reabsorption | 1 | 2015 | 7 | 0.230 |
Why?
|
| Nephrostomy, Percutaneous | 1 | 2015 | 30 | 0.230 |
Why?
|
| Kidney Tubules, Distal | 1 | 2015 | 19 | 0.230 |
Why?
|
| Medullary Sponge Kidney | 1 | 2015 | 6 | 0.230 |
Why?
|
| Gene Library | 1 | 2005 | 134 | 0.230 |
Why?
|
| Renal Elimination | 1 | 2015 | 8 | 0.230 |
Why?
|
| Lithotripsy | 1 | 2015 | 45 | 0.220 |
Why?
|
| Point Mutation | 1 | 2005 | 247 | 0.220 |
Why?
|
| Nephrolithiasis | 1 | 2015 | 25 | 0.220 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 2015 | 71 | 0.220 |
Why?
|
| Kidney Medulla | 1 | 2014 | 80 | 0.210 |
Why?
|
| Durapatite | 1 | 2014 | 36 | 0.210 |
Why?
|
| Vitamin D Deficiency | 1 | 2015 | 107 | 0.210 |
Why?
|
| Hyperoxaluria, Primary | 1 | 2013 | 4 | 0.210 |
Why?
|
| Hot Temperature | 2 | 2017 | 217 | 0.200 |
Why?
|
| Oxalates | 1 | 2013 | 49 | 0.200 |
Why?
|
| Thiazides | 1 | 2013 | 16 | 0.200 |
Why?
|
| Chlorthalidone | 1 | 2013 | 18 | 0.200 |
Why?
|
| Parathyroid Glands | 1 | 2013 | 75 | 0.200 |
Why?
|
| Molecular Chaperones | 2 | 2016 | 127 | 0.200 |
Why?
|
| Osteogenesis | 1 | 2015 | 277 | 0.200 |
Why?
|
| Transcription, Genetic | 5 | 2015 | 1191 | 0.200 |
Why?
|
| Diuretics | 1 | 2013 | 79 | 0.190 |
Why?
|
| Vitamin D | 1 | 2015 | 273 | 0.190 |
Why?
|
| Proteomics | 3 | 2018 | 268 | 0.190 |
Why?
|
| Binding, Competitive | 1 | 2022 | 147 | 0.180 |
Why?
|
| Pyruvate Kinase | 1 | 2021 | 14 | 0.180 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2015 | 258 | 0.170 |
Why?
|
| Escherichia coli | 2 | 2018 | 627 | 0.170 |
Why?
|
| Amyloid | 1 | 2021 | 105 | 0.170 |
Why?
|
| Cyanobacteria | 1 | 2020 | 114 | 0.160 |
Why?
|
| Sequence Alignment | 3 | 2017 | 360 | 0.150 |
Why?
|
| Cell Compartmentation | 1 | 2019 | 70 | 0.150 |
Why?
|
| Cell Cycle Proteins | 1 | 2021 | 412 | 0.150 |
Why?
|
| Rhodopseudomonas | 1 | 2018 | 51 | 0.140 |
Why?
|
| Drosophila melanogaster | 3 | 2014 | 633 | 0.140 |
Why?
|
| Cytoplasm | 1 | 2019 | 288 | 0.140 |
Why?
|
| Nitrogen | 1 | 2018 | 79 | 0.140 |
Why?
|
| Protein Binding | 1 | 2022 | 1560 | 0.140 |
Why?
|
| RNA, Messenger | 3 | 2015 | 2090 | 0.140 |
Why?
|
| Intrinsically Disordered Proteins | 1 | 2017 | 13 | 0.130 |
Why?
|
| Symbiosis | 1 | 2018 | 134 | 0.130 |
Why?
|
| Proline | 1 | 2017 | 56 | 0.130 |
Why?
|
| Liposomes | 2 | 2015 | 99 | 0.130 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2017 | 102 | 0.130 |
Why?
|
| Ribonucleases | 1 | 2017 | 97 | 0.130 |
Why?
|
| Amino Acid Sequence | 3 | 2017 | 2090 | 0.120 |
Why?
|
| Protein Domains | 1 | 2017 | 164 | 0.120 |
Why?
|
| Biological Evolution | 1 | 2024 | 1030 | 0.120 |
Why?
|
| Humans | 17 | 2016 | 96093 | 0.120 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2015 | 36 | 0.120 |
Why?
|
| Cycloheximide | 1 | 2015 | 58 | 0.120 |
Why?
|
| Bacterial Proteins | 2 | 2012 | 922 | 0.120 |
Why?
|
| Phylogeny | 2 | 2014 | 1275 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 2781 | 0.110 |
Why?
|
| Anticodon | 1 | 2014 | 19 | 0.110 |
Why?
|
| Animals | 7 | 2015 | 28915 | 0.110 |
Why?
|
| Sarcoma, Ewing | 1 | 2015 | 43 | 0.110 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2015 | 66 | 0.110 |
Why?
|
| Sucrose | 1 | 2015 | 67 | 0.110 |
Why?
|
| Postprandial Period | 2 | 2015 | 48 | 0.110 |
Why?
|
| Camptothecin | 1 | 2015 | 204 | 0.100 |
Why?
|
| Fasting | 2 | 2015 | 164 | 0.100 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2015 | 124 | 0.100 |
Why?
|
| Molecular Sequence Data | 3 | 2014 | 3040 | 0.100 |
Why?
|
| Methylobacterium extorquens | 1 | 2012 | 1 | 0.100 |
Why?
|
| Carbon-Nitrogen Ligases | 1 | 2012 | 6 | 0.100 |
Why?
|
| Likelihood Functions | 1 | 2013 | 257 | 0.100 |
Why?
|
| Kinetics | 1 | 2014 | 1562 | 0.090 |
Why?
|
| Base Sequence | 1 | 2014 | 2344 | 0.090 |
Why?
|
| Protein Denaturation | 1 | 2010 | 109 | 0.080 |
Why?
|
| Biopsy | 2 | 2015 | 1220 | 0.080 |
Why?
|
| Luminescent Proteins | 1 | 2010 | 145 | 0.080 |
Why?
|
| Middle Aged | 6 | 2015 | 28361 | 0.080 |
Why?
|
| Nuclear Proteins | 1 | 2015 | 750 | 0.080 |
Why?
|
| Adult | 6 | 2015 | 28716 | 0.080 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2012 | 282 | 0.080 |
Why?
|
| Chaperonins | 1 | 2009 | 10 | 0.080 |
Why?
|
| Genetic Code | 1 | 2009 | 26 | 0.080 |
Why?
|
| Female | 8 | 2015 | 50030 | 0.080 |
Why?
|
| Sequence Analysis, Protein | 2 | 2008 | 28 | 0.080 |
Why?
|
| Protein Stability | 1 | 2009 | 106 | 0.080 |
Why?
|
| Male | 7 | 2015 | 45871 | 0.070 |
Why?
|
| Nerve Tissue | 1 | 2008 | 8 | 0.070 |
Why?
|
| Models, Biological | 2 | 2015 | 1810 | 0.070 |
Why?
|
| Probability | 2 | 2005 | 365 | 0.070 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2007 | 78 | 0.070 |
Why?
|
| Antibody Affinity | 1 | 2007 | 38 | 0.070 |
Why?
|
| Aged | 4 | 2015 | 20962 | 0.060 |
Why?
|
| Computer Simulation | 2 | 2008 | 1158 | 0.060 |
Why?
|
| Caenorhabditis elegans | 1 | 2008 | 246 | 0.060 |
Why?
|
| Temperature | 1 | 2007 | 426 | 0.060 |
Why?
|
| Time Factors | 2 | 2015 | 5585 | 0.060 |
Why?
|
| Genes, Duplicate | 1 | 2005 | 20 | 0.060 |
Why?
|
| Poisson Distribution | 1 | 2005 | 49 | 0.060 |
Why?
|
| Fluorescence | 1 | 2005 | 106 | 0.060 |
Why?
|
| Peptide Fragments | 1 | 2007 | 477 | 0.060 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 1034 | 0.060 |
Why?
|
| Protein Structure, Secondary | 1 | 2006 | 342 | 0.060 |
Why?
|
| Antibodies | 1 | 2007 | 356 | 0.060 |
Why?
|
| Protein Conformation | 3 | 2020 | 935 | 0.060 |
Why?
|
| Ammonium Chloride | 1 | 2015 | 22 | 0.060 |
Why?
|
| Least-Squares Analysis | 1 | 2015 | 50 | 0.060 |
Why?
|
| Nanoparticles | 1 | 2007 | 197 | 0.060 |
Why?
|
| Bicarbonates | 1 | 2015 | 58 | 0.060 |
Why?
|
| Water-Electrolyte Balance | 1 | 2015 | 70 | 0.060 |
Why?
|
| Sus scrofa | 1 | 2015 | 52 | 0.060 |
Why?
|
| Phosphorus | 1 | 2015 | 119 | 0.060 |
Why?
|
| Nonlinear Dynamics | 1 | 2015 | 74 | 0.060 |
Why?
|
| Magnesium | 1 | 2015 | 178 | 0.050 |
Why?
|
| Models, Chemical | 1 | 2005 | 187 | 0.050 |
Why?
|
| Amino Acids | 1 | 2005 | 262 | 0.050 |
Why?
|
| Structure-Activity Relationship | 1 | 2005 | 436 | 0.050 |
Why?
|
| Urodynamics | 1 | 2015 | 130 | 0.050 |
Why?
|
| Genes | 1 | 2005 | 308 | 0.050 |
Why?
|
| Risk Factors | 2 | 2015 | 5960 | 0.050 |
Why?
|
| Dietary Supplements | 1 | 2015 | 133 | 0.050 |
Why?
|
| Databases, Genetic | 1 | 2005 | 282 | 0.050 |
Why?
|
| ErbB Receptors | 1 | 2007 | 513 | 0.050 |
Why?
|
| Gene Expression Regulation, Bacterial | 2 | 2018 | 220 | 0.050 |
Why?
|
| Sodium | 1 | 2015 | 340 | 0.050 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2014 | 138 | 0.050 |
Why?
|
| Thermodynamics | 1 | 2005 | 329 | 0.050 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 2417 | 0.050 |
Why?
|
| Glomerular Filtration Rate | 1 | 2015 | 289 | 0.050 |
Why?
|
| Linear Models | 1 | 2015 | 438 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 1 | 2005 | 312 | 0.050 |
Why?
|
| Hyperoxaluria | 1 | 2013 | 26 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 701 | 0.050 |
Why?
|
| Decision Support Techniques | 1 | 2015 | 186 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2005 | 930 | 0.050 |
Why?
|
| Renal Insufficiency | 1 | 2013 | 99 | 0.050 |
Why?
|
| Calcinosis | 1 | 2014 | 232 | 0.050 |
Why?
|
| Escherichia coli Proteins | 2 | 2018 | 190 | 0.050 |
Why?
|
| Genetics, Population | 1 | 2006 | 437 | 0.050 |
Why?
|
| Young Adult | 2 | 2015 | 7025 | 0.050 |
Why?
|
| Fructosediphosphates | 1 | 2021 | 2 | 0.050 |
Why?
|
| Computational Biology | 1 | 2005 | 584 | 0.040 |
Why?
|
| Sex Factors | 1 | 2015 | 1133 | 0.040 |
Why?
|
| Kidney Diseases | 1 | 2014 | 325 | 0.040 |
Why?
|
| Blood Pressure | 1 | 2015 | 929 | 0.040 |
Why?
|
| Adolescent | 2 | 2014 | 9896 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2015 | 1958 | 0.040 |
Why?
|
| Adenosine Triphosphate | 1 | 2021 | 329 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 1874 | 0.040 |
Why?
|
| Mice | 2 | 2015 | 12539 | 0.040 |
Why?
|
| PII Nitrogen Regulatory Proteins | 1 | 2018 | 1 | 0.040 |
Why?
|
| Ammonium Compounds | 1 | 2018 | 10 | 0.040 |
Why?
|
| Fermentation | 1 | 2018 | 15 | 0.040 |
Why?
|
| Culture Media | 1 | 2018 | 150 | 0.040 |
Why?
|
| Insulin | 1 | 2013 | 1190 | 0.030 |
Why?
|
| Biomarkers | 1 | 2015 | 1932 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2018 | 172 | 0.030 |
Why?
|
| Cation Transport Proteins | 1 | 2018 | 70 | 0.030 |
Why?
|
| Carbon | 1 | 2018 | 97 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2015 | 1096 | 0.030 |
Why?
|
| Prognosis | 1 | 2015 | 4029 | 0.030 |
Why?
|
| Infant | 1 | 2013 | 3363 | 0.030 |
Why?
|
| Algorithms | 1 | 2015 | 2014 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 259 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2013 | 3974 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 2 | 2008 | 750 | 0.030 |
Why?
|
| Regression Analysis | 2 | 2008 | 599 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2015 | 2777 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2015 | 297 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2015 | 214 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2015 | 322 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2015 | 528 | 0.020 |
Why?
|
| United States | 1 | 2015 | 7767 | 0.020 |
Why?
|
| Neoplasms | 1 | 2007 | 3248 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2012 | 223 | 0.020 |
Why?
|
| Macrophages | 1 | 2015 | 626 | 0.020 |
Why?
|
| Models, Molecular | 2 | 2005 | 1375 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 2883 | 0.020 |
Why?
|
| Enzyme Stability | 1 | 2007 | 41 | 0.020 |
Why?
|
| Biotransformation | 1 | 2007 | 49 | 0.020 |
Why?
|
| Heme | 1 | 2007 | 64 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 2550 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2008 | 168 | 0.020 |
Why?
|
| Topotecan | 1 | 2007 | 46 | 0.020 |
Why?
|
| Epidermal Growth Factor | 1 | 2007 | 116 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2007 | 368 | 0.020 |
Why?
|
| Solubility | 1 | 2007 | 190 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2008 | 527 | 0.020 |
Why?
|
| Pharmaceutical Preparations | 1 | 2007 | 97 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2006 | 311 | 0.010 |
Why?
|
| Static Electricity | 1 | 2005 | 97 | 0.010 |
Why?
|
| Cell Survival | 1 | 2007 | 1030 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2006 | 910 | 0.010 |
Why?
|
| Drosophila Proteins | 1 | 2008 | 523 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2005 | 503 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 2059 | 0.010 |
Why?
|